Skip to main content
. 2022 Aug 15;182(10):1025–1034. doi: 10.1001/jamainternmed.2022.3355

Table 1. Characteristics of BP Home Participants, by Study Arm.

Characteristic SMBP, No. (%) Standardized mean difference
Standard Enhanced with smartphone application
No. 1050 1051 NA
Self-reported
Age, mean (SD), y 58 (13) 59 (13) 0.04
Female sex 602 (57) 589 (56) 0.03
Male sex 448 (43) 462 (44) 0.03
Race and ethnicity 0.12
Hispanic/Latinx, any race 101 (10) 79 (8) .12
Non-Hispanic
Asian 22 (2) 6 (0.6)
Black 226 (22) 239 (23)
White 666 (63) 676 (64)
Other/multiraciald 35 (3) 51 (5)
Subjective social status, mean (SD)a 6.2 (2.2) 6.2 (2.2) 0
Eligibility BP, mean (SD), mm Hg
Systolic 158 (12) 157 (11) −0.06
Diastolic 88 (12) 88 (11) −0.04
Satisfaction with BP management, 1-5 scale, mean (SD)b
Overall 3.7 (1.2) 3.8 (1.1) 0.02
Your health care clinician 4.3 (1.0) 4.3 (1.1) −0.02
Your BP medications 3.7 (1.2) 3.7 (1.2) −0.01
Comfort using technology like a computer or smartphone, 1-5 scale, mean (SD) 4.1 (1.1) 4.1 (1.1) −0.04
From electronic health records c
Total with linked medical record data 1034 (98) 1028 (98) −0.05
Smoking status
Current 218 (21) 208 (20) 0.03
Past 305 (29) 306 (30)
Never 460 (44) 463 (45)
Missing or unclear in EHR data 51 (5) 51 (5)
Diabetes 200 (19) 217 (21) 0.04
Congestive heart failure 30 (2.9) 33 (3.2) 0.02
Coronary artery disease 75 (7.3) 93 (9.1) 0.07
Chronic obstructive pulmonary disease 31 (3.0) 46 (4.5) 0.08
End stage kidney disease 16 (1.6) 12 (1.2) −0.03
No. of current BP medication classes of medications prescribed during the past year
0 338 (33) 307 (30) 0.08
1 239 (23) 249 (24)
2 218 (21) 234 (23)
3 134 (13) 128 (12)
≥4 105 (10) 110 (11)
BP medication class prescribed in the past year
Thiazide or thiazide-like diuretic 295 (29) 261 (25) −0.07
ACE inhibitor 304 (29) 282 (27) −0.04
ARB 184 (18) 201 (20) 0.05
Calcium channel blocker 298 (29) 304 (30) 0.02
β-Blocker 272 (26) 309 (30) 0.08
α-Blocker 18 (1.7) 28 (2.7) 0.07
Aldosterone inhibitor 28 (2.7) 38 (3.7) 0.06
K-sparing diuretic 18 (1.7) 12 (1.2) −0.05
Centrally acting 49 (4.7) 45 (4.4) −0.02
Renin antagonist 0 0 0
Vasodilator 46 (4.5) 66 (6.4) 0.09
Loop diuretic 61 (5.9) 79 (7.7) 0.07
Fixed-dose combination medication prescribed during past year 85 (8.2) 71 (6.9) −0.05
No. of ambulatory visits with BP measured during the past year
0 56 (5.4) 43 (4.2) 0.10
1 205 (20) 209 (20)
2 186 (18) 174 (17)
3 162 (16) 143 (14)
≥4 425 (41) 459 (45)
Self-reported eligibility SBP/DBP vs past clinic SBP/DBP
Exact match at most recent visit 635 (61) 631 (61) 0
Exact match, not at most recent visit 205 (20) 206 (20)
No exact match 194 (19) 191 (19)
Lowest BP at most recent encounter, mean (SD), mm Hg
Systolic 150 (16) 150 (17) −0.03
Diastolic 85 (12) 85 (12) −0.01

Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BP, blood pressure; EHR, electronic health record; NA, not applicable; SMBP, self-measured blood pressure.

a

MacArthur Subjective Social Scale, 1-10 scale.22 One participant was missing data for this baseline characteristic because of a technical malfunction.

b

Participants were allowed to choose NA if, for example, they were not currently being treated for hypertension; these responses were excluded from calculations of the mean, SD, and P value. A total of 165 (7.9%) chose NA for “overall,” 74 (3.5%) chose NA for “your health care clinician,” and 423 (20.1%) chose NA for “your BP medications.”

c

EHR data were missing for 39 participants (Figure 1). Descriptive statistics from EHR data in the table exclude these 39 participants.

d

For descriptive purpose, participants choosing "other" or multiple categories were grouped together.